To show that albiglutide , a glucagon-like peptide-@ receptor agonist , is an effective and generally safe treatment to improve glycaemic control in patients with type @ diabetes mellitus whose hyperglycaemia is inadequately controlled with pioglitazone ( with or without metformin ) .